SMTL ID : 1vbe.3 (4 other biounits)

POLIOVIRUS (TYPE 3, SABIN STRAIN, MUTANT 242-H2) COMPLEXED WITH R78206

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-6-6-6-6-mer

Ligands

6 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)

ILE-SER-GLU-VAL.1: 4 residues within 4Å: Chain D: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain D Hydrophobic interactions: D:A.2 Hydrogen bonds: D:A.2, D:Q.3, D:Q.3, D:V.4 ILE-SER-GLU-VAL.4: 4 residues within 4Å: Chain H: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain H Hydrophobic interactions: H:A.2 Hydrogen bonds: H:A.2, H:Q.3, H:Q.3, H:V.4 ILE-SER-GLU-VAL.7: 4 residues within 4Å: Chain L: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain L Hydrophobic interactions: L:A.2 Hydrogen bonds: L:A.2, L:Q.3, L:Q.3, L:V.4 ILE-SER-GLU-VAL.10: 4 residues within 4Å: Chain P: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain P Hydrophobic interactions: P:A.2 Hydrogen bonds: P:A.2, P:Q.3, P:Q.3, P:V.4 ILE-SER-GLU-VAL.13: 4 residues within 4Å: Chain T: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain T Hydrophobic interactions: T:A.2 Hydrogen bonds: T:A.2, T:Q.3, T:Q.3, T:V.4 ILE-SER-GLU-VAL.16: 4 residues within 4Å: Chain X: A.2, Q.3, V.4, S.5 5 PLIP interactions: 5 interactions with chain X Hydrophobic interactions: X:A.2 Hydrogen bonds: X:A.2, X:Q.3, X:Q.3, X:V.4

6 x J78: (METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE(Non-covalent)

J78.2: 17 residues within 4Å: Chain A: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain C: A.24, I.25 11 PLIP interactions: 10 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: A:Y.110, A:Y.157, A:Y.157, A:P.179, A:I.181, A:I.192, A:V.194, A:F.236, A:F.236, C:A.24 pi-Stacking: A:Y.203 J78.5: 17 residues within 4Å: Chain E: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain G: A.24, I.25 11 PLIP interactions: 10 interactions with chain E, 1 interactions with chain G Hydrophobic interactions: E:Y.110, E:Y.157, E:Y.157, E:P.179, E:I.181, E:I.192, E:V.194, E:F.236, E:F.236, G:A.24 pi-Stacking: E:Y.203 J78.8: 17 residues within 4Å: Chain I: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain K: A.24, I.25 11 PLIP interactions: 1 interactions with chain K, 10 interactions with chain I Hydrophobic interactions: K:A.24, I:Y.110, I:Y.157, I:Y.157, I:P.179, I:I.181, I:I.192, I:V.194, I:F.236, I:F.236 pi-Stacking: I:Y.203 J78.11: 17 residues within 4Å: Chain M: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain O: A.24, I.25 11 PLIP interactions: 1 interactions with chain O, 10 interactions with chain M Hydrophobic interactions: O:A.24, M:Y.110, M:Y.157, M:Y.157, M:P.179, M:I.181, M:I.192, M:V.194, M:F.236, M:F.236 pi-Stacking: M:Y.203 J78.14: 17 residues within 4Å: Chain Q: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain S: A.24, I.25 11 PLIP interactions: 10 interactions with chain Q, 1 interactions with chain S Hydrophobic interactions: Q:Y.110, Q:Y.157, Q:Y.157, Q:P.179, Q:I.181, Q:I.192, Q:V.194, Q:F.236, Q:F.236, S:A.24 pi-Stacking: Q:Y.203 J78.17: 17 residues within 4Å: Chain U: I.108, T.109, Y.110, M.130, L.132, I.155, Y.157, P.179, I.181, I.192, V.194, V.197, Y.203, F.236, L.239 Chain W: A.24, I.25 11 PLIP interactions: 10 interactions with chain U, 1 interactions with chain W Hydrophobic interactions: U:Y.110, U:Y.157, U:Y.157, U:P.179, U:I.181, U:I.192, U:V.194, U:F.236, U:F.236, W:A.24 pi-Stacking: U:Y.203

6 x MYR: MYRISTIC ACID(Covalent)

MYR.3: 11 residues within 4Å: Chain D: G.1, A.2, I.29, Y.31 Chain H: A.2, V.4, T.27, T.28, I.29, Y.31 Ligands: MYR.6 5 PLIP interactions: 2 interactions with chain D, 3 interactions with chain H Hydrophobic interactions: D:I.29, D:Y.31, H:A.2, H:I.29 Hydrogen bonds: H:T.27 MYR.6: 5 residues within 4Å: Chain H: G.1, A.2, I.29, Y.31 Ligands: MYR.3 2 PLIP interactions: 2 interactions with chain H Hydrophobic interactions: H:I.29, H:Y.31 MYR.9: 5 residues within 4Å: Chain L: G.1, A.2, I.29, Y.31 Ligands: MYR.12 2 PLIP interactions: 2 interactions with chain L Hydrophobic interactions: L:I.29, L:Y.31 MYR.12: 11 residues within 4Å: Chain L: A.2, V.4, T.27, T.28, I.29, Y.31 Chain P: G.1, A.2, I.29, Y.31 Ligands: MYR.9 5 PLIP interactions: 3 interactions with chain L, 2 interactions with chain P Hydrophobic interactions: L:A.2, L:I.29, P:I.29, P:Y.31 Hydrogen bonds: L:T.27 MYR.15: 11 residues within 4Å: Chain T: G.1, A.2, I.29, Y.31 Chain X: A.2, V.4, T.27, T.28, I.29, Y.31 Ligands: MYR.18 5 PLIP interactions: 3 interactions with chain X, 2 interactions with chain T Hydrophobic interactions: X:A.2, X:I.29, T:I.29, T:Y.31 Hydrogen bonds: X:T.27 MYR.18: 5 residues within 4Å: Chain X: G.1, A.2, I.29, Y.31 Ligands: MYR.15 2 PLIP interactions: 2 interactions with chain X Hydrophobic interactions: X:I.29, X:Y.31

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)

Release Date

1996-07-11

Peptides

POLIOVIRUS TYPE 3: AEIMQU
POLIOVIRUS TYPE 3: BFJNRV
POLIOVIRUS TYPE 3: CGKOSW
POLIOVIRUS TYPE 3: DHLPTX

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

E
1

I
1

M
1

Q
1

U
1

B
2

F
2

J
2

N
2

R
2

V
2

C
3

G
3

K
3

O
3

S
3

W
3

D
4

H
4

L
4

P
4

T
4

X
4

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

POLIOVIRUS TYPE 3

Related Entries With Identical Sequence